To view this email as a web page, click here.

 
News from the 87th Annual Congress of the European Atherosclerosis Society
 
Fixed-dose Lipid-lowering Combination Bests Either Drug Alone
MAASTRICHT, The Netherlands--The significant combined effect of bempedoic acid and ezetimibe on LDL-C in patients at high risk for CV events may suggest a new era of non-statin therapy.
Read more
 
High Lipoprotein(a) Levels not Linked to Increased Prothrombotic Effects
MAASTRICHT, The Netherlands—Study results suggest that clinical trials of novel treatments targeting Lp(a) will not be affected by subjects with CV disease receiving antiplatelet therapy.
Read more
 
PLUS: MORE ON CVD PREVENTION FROM PRACTICAL CARDIOLOGY
 
9 Questions on Primary CV Disease Prevention based on 2019 ACC/AHA Guidelines
Fish Oil Prescribed vs Fish Oil Taken: A First Look
Medical Nutrition Therapy for Dyslipidemia: Costs and Benefits
 
ADVERTISEMENT
Upgrade your skills with the ECG Certificate course
—the efficient and affordable way to advance competencies of staff who already perform ECGs. Earn a certificate, digital badge, and 5 CEs. All online. From the medical assistant certification specialists, AMT. Read more.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.